Anixa Biosciences (ANIX) President Michael Catelani Buys 5,500 Shares

What Happened
Michael Catelani, who serves as President, COO and CFO of Anixa Biosciences (ANIX), purchased 5,500 shares on 2026-09-30 at $2.84 per share for a total cash outlay of $15,620. The transaction is reported as a purchase (code P), a direct buy rather than an option exercise or gift.

Key Details

• Transaction date: 2026-09-30
• Transaction type/code: Purchase (P) — open market or private purchase reported
• Price and amount: 5,500 shares at $2.84 each; total $15,620
• Filing: Form 4 filed with accession no. 0001493152-26-045053 for period/report date 2026-09-30
• Shares owned after transaction: Not specified in the provided summary (see full Form 4 for post-transaction holdings)
• Footnotes / special plans: No 10b5-1 plan, tax withholding, or other footnotes noted in the provided data
• Timeliness: Reported for the same report date; no late filing indicated in the provided information

Context
This was a straightforward purchase of common stock by an active executive — purchases are often viewed by investors as a stronger signal of insider conviction than routine sales, but they do not prove future performance. This transaction is not an option exercise or gift, so it represents a direct increase in the insider’s equity stake. For full ownership totals and any additional notes, review the complete Form 4 linked by the accession number.